Status:
COMPLETED
The Experiences of People Who Live With Glanzmanns Thrombasthenia.
Lead Sponsor:
Haemnet
Collaborating Sponsors:
Hemab ApS
Conditions:
Glanzmann Thrombasthenia
Eligibility:
All Genders
Up to 100 years
Brief Summary
To understand the lived experiences of people with Glanzmanns Thrombasthenia
Detailed Description
A qualitative study of people with Glanzmanns Thrombasthenia including an on-line survey, qualitative in-depth interviews and bleed diary completion.
Eligibility Criteria
Inclusion
- Clinical diagnosis of congenital (inherited) Glanzmanns Thrombasthenia
Exclusion
- Acquired Glanzmanns Thrombasthenia
Key Trial Info
Start Date :
April 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 27 2023
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT05315232
Start Date
April 27 2022
End Date
April 27 2023
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom, OX3 7LE